These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32622980)

  • 1. Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across Permeapad
    Ilie AR; Griffin BT; Brandl M; Bauer-Brandl A; Jacobsen AC; Vertzoni M; Kuentz M; Kolakovic R; Holm R
    Eur J Pharm Sci; 2020 Sep; 152():105452. PubMed ID: 32622980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients.
    Ilie AR; Griffin BT; Vertzoni M; Kuentz M; Cuyckens F; Wuyts K; Kolakovic R; Holm R
    Drug Dev Ind Pharm; 2020 Dec; 46(12):2051-2060. PubMed ID: 33124918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring precipitation inhibitors to improve in vivo absorption of cinnarizine from supersaturated lipid-based drug delivery systems.
    Ilie AR; Griffin BT; Vertzoni M; Kuentz M; Kolakovic R; Prudic-Paus A; Malash A; Bohets H; Herman J; Holm R
    Eur J Pharm Sci; 2021 Apr; 159():105691. PubMed ID: 33359616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Phospholipids Boost or Attenuate Drug Absorption? In Vitro and In Vivo Evaluation of Mono- and Diacyl Phospholipid-Based Solid Dispersions of Celecoxib.
    Jacobsen AC; Ejskjær L; Brandl M; Holm R; Bauer-Brandl A
    J Pharm Sci; 2021 Jan; 110(1):198-207. PubMed ID: 32827494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digestion is a critical element for absorption of cinnarizine from supersaturated lipid-based type I formulations.
    Paulus F; Bauer-Brandl A; Stappaerts J; Holm R
    Eur J Pharm Sci; 2024 Jan; 192():106634. PubMed ID: 37951315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of cinnarizine from type II lipid-based formulations: Impact of lipid chain length, supersaturation, digestion, and precipitation inhibition.
    Paulus F; Holm R; Stappaerts J; Bauer-Brandl A
    Eur J Pharm Sci; 2024 Jun; 197():106765. PubMed ID: 38608735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supersaturated lipid-based drug delivery systems - exploring impact of lipid composition type and drug properties on supersaturability and physical stability.
    Ilie AR; Griffin BT; Kolakovic R; Vertzoni M; Kuentz M; Holm R
    Drug Dev Ind Pharm; 2020 Mar; 46(3):356-364. PubMed ID: 31975613
    [No Abstract]   [Full Text] [Related]  

  • 8. Supersaturated polymeric micelles for oral cyclosporine A delivery.
    Yu H; Xia D; Zhu Q; Zhu C; Chen D; Gan Y
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1325-36. PubMed ID: 23954511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Solidification on the in vitro Solubilisation of Blonanserin Loaded Supersaturated Lipid-Based Oral Formulations.
    Møller A; Schultz HB; Meola TR; Müllertz A; Prestidge CA
    Eur J Pharm Sci; 2021 Feb; 157():105640. PubMed ID: 33189902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supersaturated Silica-Lipid Hybrid Oral Drug Delivery Systems: Balancing Drug Loading and In Vivo Performance.
    Schultz HB; Kovalainen M; Peressin KF; Thomas N; Prestidge CA
    J Pharmacol Exp Ther; 2019 Sep; 370(3):742-750. PubMed ID: 30552294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
    McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
    Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
    Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
    Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
    Dahan A; Hoffman A
    Eur J Pharm Biopharm; 2007 Aug; 67(1):96-105. PubMed ID: 17329087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous lipolysis/permeation in vitro model, for the estimation of bioavailability of lipid based drug delivery systems.
    Bibi HA; Holm R; Bauer-Brandl A
    Eur J Pharm Biopharm; 2017 Aug; 117():300-307. PubMed ID: 28478159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence on the oral bioavailability of solubilized and suspended drug in a lipid nanoparticle formulation: In vitro and in vivo evaluation.
    Elbrink K; Van Hees S; Roelant D; Loomans T; Holm R; Kiekens F
    Eur J Pharm Biopharm; 2022 Oct; 179():1-10. PubMed ID: 36031014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
    Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
    Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid based formulations as supersaturating oral delivery systems: From current to future industrial applications.
    Holm R; Kuentz M; Ilie-Spiridon AR; Griffin BT
    Eur J Pharm Sci; 2023 Oct; 189():106556. PubMed ID: 37543063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enabling superior drug loading in lipid-based formulations with lipophilic salts for a brick dust molecule: Exploration of lipophilic counterions and in vitro-in vivo evaluation.
    Sirvi A; Jadhav K; Sangamwar AT
    Int J Pharm; 2024 May; 656():124108. PubMed ID: 38604540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib.
    Tan A; Davey AK; Prestidge CA
    Pharm Res; 2011 Sep; 28(9):2273-87. PubMed ID: 21560021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).
    Thomas N; Holm R; Müllertz A; Rades T
    J Control Release; 2012 May; 160(1):25-32. PubMed ID: 22405903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.